U. S. Food and Drug Administration • Center for Drug Evaluation and Research

FDA Review Divisions Responsible for Oncology Products

The Office of Oncology Drug Products (OODP) is responsible for making safe and effective drug and therapeutic biologic treatments for cancer available to the U.S. public. OODP has the following components:

• Organization Chart
• Immediate Office
• Division of Biologic Oncology Products
• Division of Drug Oncology Products
• Division of Medical Imaging and Hematology Products
• Oncology Program
• Radioactive Drug Research Committee Program

PDF requires the free Adobe Acrobat Reader

FDA/Center for Drug Evaluation and Research
Last Updated: August 2, 2006
Originator: OTCOM/DLIS
HTML by  GYC;SH;CSA